Abstract
Purpose
To evaluate whether exposure to glucocorticoids represents a risk factor for the development of central serous chorioretinopathy (CSCR).
Methods
Prospective, case–control study. Thirty-eight consecutive patients with acute CSCR were asked to answer a specific questionnaire regarding the use of glucocorticoids, in any form, during the last month before the onset of the symptoms. An age- and sex-matched control group was also recruited. It consisted of patients attending the outpatient department for a condition other than CSCR, who were asked to answer the same questionnaire.
Results
Use of glucocorticoids was recorded in 11 of 38 patients (28.9%) with CSCR; 8 of them were men and 3 women. In the control group, use of glucocorticoids was recorded in 2 of 38 patients (5.2%), 1 man and 1 woman. The difference between the two groups is statistically significant (odds ratio=7.33, 95% CI=1.49–35.85, P=0.006).
Conclusion
In this prospective, case–control study, we found that glucocorticoid use represents a risk factor for the development of CSCR.
This is a preview of subscription content, log in via an institution to check access.
References
Bouzas EA, Scott MH, Mastorakos G, et al (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111:1229–1233
Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448
Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al (2002) Corticosteroids and central serous chorioretinopathy. Ophthalmology 109:1834–1837
Jain IS, Singh K (1966) Maculopathy: a corticosteroid side-effect. J All India Ophthalmol Soc 14:250–252
Lowder CY, Gutman FA, Zegarra H, et al (1981) Macular and paramacular detachment of the neurosensory retina associated with systemic diseases. Trans Am Ophthalmol Soc 79:347–370
Tittl MK, Spaide RF, Wong D, et al (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128:63–68
Ulbig MR, Riordan-Eva P, Holz FG, et al (1993) Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol 116:410–413
von Graefe A (1866) Ueber centrale recidivierende retinitis. Albrecht v Graefes Arch Klin Exp Ophthalmol 12:211–215
Wakakura M, Ishikawa S (1984) Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 68:329–331
Wakakura M, Song E, Ishikawa S (1997) Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol 41:180–185
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karadimas, P., Bouzas, E.A. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study. Graefe's Arch Clin Exp Ophthalmol 242, 800–802 (2004). https://doi.org/10.1007/s00417-004-0885-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-004-0885-z